Charles Schwab Investment Management Inc. decreased its holdings in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 27.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 621,569 shares of the company's stock after selling 238,407 shares during the period. Charles Schwab Investment Management Inc. owned about 1.24% of Enhabit worth $4,910,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Gladius Capital Management LP bought a new stake in Enhabit during the 2nd quarter worth approximately $31,000. Quarry LP increased its stake in shares of Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company's stock worth $33,000 after purchasing an additional 2,621 shares in the last quarter. Stoneridge Investment Partners LLC bought a new stake in shares of Enhabit during the 3rd quarter valued at $81,000. Canada Pension Plan Investment Board purchased a new position in shares of Enhabit during the 2nd quarter valued at $93,000. Finally, AQR Capital Management LLC bought a new position in Enhabit in the 2nd quarter worth $94,000.
Analysts Set New Price Targets
A number of research firms recently commented on EHAB. Jefferies Financial Group raised Enhabit from a "hold" rating to a "buy" rating and boosted their price target for the stock from $8.25 to $9.50 in a report on Monday, December 9th. Leerink Partners reiterated a "market perform" rating and set a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Enhabit presently has a consensus rating of "Hold" and a consensus price target of $8.75.
Check Out Our Latest Report on EHAB
Enhabit Price Performance
Shares of Enhabit stock remained flat at $8.52 on Friday. The stock had a trading volume of 207,556 shares, compared to its average volume of 571,605. The firm's 50-day simple moving average is $7.56 and its 200-day simple moving average is $8.31. Enhabit, Inc. has a 12-month low of $6.85 and a 12-month high of $11.74. The firm has a market capitalization of $428.42 million, a price-to-earnings ratio of -3.67 and a beta of 1.89. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85.
Enhabit (NYSE:EHAB - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The firm had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. During the same quarter last year, the business posted $0.03 EPS. As a group, analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.
Insider Transactions at Enhabit
In other news, Director Stuart M. Mcguigan bought 15,000 shares of the firm's stock in a transaction on Tuesday, December 10th. The stock was acquired at an average cost of $8.81 per share, with a total value of $132,150.00. Following the transaction, the director now directly owns 46,810 shares in the company, valued at approximately $412,396.10. This trade represents a 47.15 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jeffrey Bolton bought 4,000 shares of the stock in a transaction on Thursday, December 12th. The stock was purchased at an average price of $8.69 per share, with a total value of $34,760.00. Following the completion of the acquisition, the director now directly owns 98,144 shares in the company, valued at approximately $852,871.36. This trade represents a 4.25 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.90% of the company's stock.
About Enhabit
(
Free Report)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Further Reading
Before you consider Enhabit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.
While Enhabit currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
